• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Sierra Oncology, Inc. - Common Stock (NQ:SRRA)

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Jun 30, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 54.96 (50)
Ask (Size) 55.00 (2)
Prev. Close 54.99
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding 24,419,349
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
The Daily Biotech Pulse: Addex Terminates Parkinson's Study, Expanded Use Of Rhythm's Obesity Drug, FDA Approval For AbbVie's Skyrizi In Crohn's Disease ↗
June 17, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
Sierra Oncology Announces Submission of New Drug Application for Momelotinib to US Food & Drug Administration
June 17, 2022
From Sierra Oncology
Via Business Wire

Performance

More News

Read More
News headline image
6 Biotech Stocks to Buy Now Ahead of These June Catalysts ↗
June 03, 2022
Via InvestorPlace
News headline image
3 Biotech Stocks to Buy Before They Boom ↗
June 01, 2022
Via InvestorPlace
News headline image
Recap: Sierra Oncology Q1 Earnings ↗
May 06, 2022
Via Benzinga
News headline image
Analyst Ratings for Sierra Oncology ↗
April 14, 2022
Via Benzinga
News headline image
Momelotinib Pivotal Phase 3 Data Receives Oral Presentation at American Society of Clinical Oncology Annual Meeting
May 26, 2022
From Sierra Oncology
Via Business Wire
News headline image
Sierra Oncology Announces Oral Presentation of Momelotinib Pivotal Phase 3 Data at European Hematology Association Annual Meeting
May 12, 2022
From Sierra Oncology
Via Business Wire
News headline image
Sierra Oncology Reports First Quarter 2022 Results
May 06, 2022
From Sierra Oncology
Via Business Wire
News headline image
Sierra Oncology Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
May 05, 2022
From Sierra Oncology
Via Business Wire
News headline image
SIERRA ONCOLOGY INVESTOR ALERT - Kuznicki Law PLLC Investigates Proposed Sale of Sierra Oncology, Inc - SRRA
May 02, 2022
From Kuznicki Law PLLC
Via Business Wire
News headline image
SIERRA ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sierra Oncology, Inc - SRRA
April 25, 2022
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
The Week Ahead In Biotech (April 17-April 23): J&J, Abbott Earnings, Adcom Test For TG Therapeutics And More ↗
April 17, 2022
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For April 14, 2022 ↗
April 14, 2022
Via Benzinga
News headline image
Analyzing Sierra Oncology Inc's Short Interest ↗
April 14, 2022
Via Benzinga
Advancements of CAR-T Cell Therapies Importance Grows While Cancer Cases Increasing
April 14, 2022
Via FinancialNewsMedia
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
April 13, 2022
Via Benzinga
News headline image
Why Is Creatd (CRTD) Stock Up Today? ↗
April 13, 2022
Via InvestorPlace
News headline image
Dear KLDO Stock Fans, Mark Your Calendars for April 28 ↗
April 13, 2022
Via InvestorPlace
News headline image
Why Is Sierra Oncology (SRRA) Stock Up Today? ↗
April 13, 2022
Via InvestorPlace
News headline image
Sierra Oncology Stock Is Soaring: Here's Why ↗
April 13, 2022
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For April 13, 2022 ↗
April 13, 2022
Via Benzinga
News headline image
Biotech Stock Sierra Soars On GSK Buyout As Halozyme Nabs Antares ↗
April 13, 2022
Via Investor's Business Daily
News headline image
The Daily Biotech Pulse: GlaxoSmithKline And Halozyme Go Shopping, Mylan's Insulin Glargine Recall, Turning Point Shares Lung Cancer Data And More ↗
April 13, 2022
Via Benzinga
News headline image
SRRA Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Sierra Oncology, Inc. Is Fair to Shareholders
April 13, 2022
From Halper Sadeh LLP
Via Business Wire

Frequently Asked Questions

Is Sierra Oncology, Inc. - Common Stock publicly traded?
Yes, Sierra Oncology, Inc. - Common Stock is publicly traded.
What exchange does Sierra Oncology, Inc. - Common Stock trade on?
Sierra Oncology, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Sierra Oncology, Inc. - Common Stock?
The ticker symbol for Sierra Oncology, Inc. - Common Stock is SRRA on the Nasdaq Stock Market
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap